South African multicentre trial with Voltaren in osteo-arthritis of the knee.
D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000814:Aniline Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005006:Ethnicity; D006801:Humans; D007717:Knee; D010003:Osteoarthritis / Q000097:blood / Q000188:drug therapy*; D010648:Phenylacetates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013019:South Africa; D014527:Uric Acid / Q000097:blood
D000700:Analgesics; D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D010648:Phenylacetates; D014527:Uric Acid; D001241:Aspirin